For the Media

Lung Cancer Initiative of North Carolina, the state’s leading nonprofit organization supporting lung cancer research and education, will host its 10th annual Evening of Hope Gala on Saturday, April 1, from 5:30-11 p.m. at North Ridge Country Club. This year’s theme will be “Roaring Towards a Cure,” and attendees are encouraged to dress in 1920s attire. The black-tie optional celebration and fundraiser will include dinner and drinks, a silent and live auction, and live music from the Carolina Moondogs.
Lung Cancer Initiative of North Carolina Hosts  Evening of Hope Gala “Roaring Towards a Cure” on April 1

Vanderbilt Team’s Discovery Offers New Insight on Lung Cancer Risk

Source: Vanderbilt University
Date: March 6, 2017
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.
Vanderbilt Team’s Discovery Offers New Insight on Lung Cancer Risk

Paige Humble Joins Lung Cancer Initiative as Executive Director

By: Lung Cancer Initiative
Date: February 1, 2017
Lung Cancer Initiative of North Carolina (LCINC), the state’s leading non-profit organization supporting lung cancer research and education, announces the appointment of Paige Humble as Executive Director effective February 16. Ms. Humble comes to LCINC from her previous position as the Associate Director of Service Line Communications and Market Development at Duke Network Services where she served as Duke’s primary liaison for marketing and brand integration efforts with Duke Health’s affiliates and Duke LifePoint hospitals. Ms. Humble has been involved with the organization, as LCINC’s presenting sponsor liaison with Duke Raleigh Hospital since the first 5K fundraiser in 2007. The Board of Directors is confident that Paige’s depth in hospital and healthcare experience will serve the organization well in achieving its vision to improve life for those affected by lung cancer in every county of the state.
Paige Humble Joins Lung Cancer Initiative as Executive Director

Hope for Leading Cause of Cancer Related Deaths

By: Lung Cancer Initiative
Date: November 15, 2016
It can be a frightening experience when receiving a cancer diagnosis. But when it is one that is the leading cause of cancer-related deaths, and takes more lives than, breast, prostate and colon cancers combined, many lose hope at the sound of hearing that they have lung cancer. That shouldn’t be the case. Anne Marie Byrd relapsed after 2 ½ years of being cancer free but this time, research allowed her to not have to endure the harsh side effects from chemotherapy treatments. Instead, she had immunotherapy infusions which allowed her own immune system to fight her lung cancer and she is now cancer free.
Hope for Leading Cause of Cancer Related Deaths

Lung Cancer Initiative of North Carolina announces its partnership with The V Foundation for Cancer Research. Together, they will fund research focused on lung cancer, specifically among the African-American population in North Carolina.
Lung Cancer Initiative and The V Foundation Expand Partnership to Fund Lung Cancer Research

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it has received a second Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA) for its anaplastic lymphoma kinase (ALK) inhibitor, Alecensa (alectinib). The latest BTD was granted for the treatment of adult patients with advanced ALK-positive non-small cell lung cancer (NSCLC) who have not received prior treatment with an ALK inhibitor.
FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

By: Cynamon Frierson
Date: September 14, 2016
At the 10th Annual LUNGe Forward 5K we will use our lungs to run, walk, laugh, breathe and dance. We use our voice to celebrate the lives of survivors and remember the lives of those we have lost to lung cancer. Lung cancer is the leading cause of cancer death in both men and women, more than breast, colon and prostate cancers combined, but the Lung Cancer Initiative of North Carolina strives to change that. On Sunday, September 25, 2016 at 1 pm, they will host the Raleigh LUNGe Forward 5K Run, Walk & Rally with Duke Raleigh Hospital as the presenting sponsor. In addition to the race, food trucks and family-friendly entertainment will also be provided.
10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

The Lung Cancer Initiative of North Carolina is pleased to announce the winners of their 2016-2017 Lung Cancer Research Fellows Program. This year, the Initiative added an additional Fellows Grant to Levine Cancer Institute bringing the total to $125,000 for five grants. As the state’s leading non-profit organization supporting lung cancer research and education, they are committed to funding North Carolina researchers.
$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

$10,000 Grant Awarded to Improve Access to Lung Cancer Screening

By: Cynamon Frierson
Date: June 28, 2016
The Lung Cancer Initiative of North Carolina, the state’s leading non-profit organization supporting lung cancer research and education, is pleased to announce Vidant Medical Center in Greenville, NC as the recipient of their $10,000 Access Grant.
$10,000 Grant Awarded to Improve Access to Lung Cancer Screening

The Lung Cancer Initiative of North Carolina announces the Inaugural Charlotte Evening of Hope Gala. The event will take place on Saturday, June 4, 2016 at the Ballantyne Hotel. The theme will be Ribbons and Pearls and the evening will be a night of celebration including dinner and drinks, silent auction, music and dancing.
Inaugural Evening of Hope Gala to Fight Lung Cancer in Charlotte

Connect With Us

  • Address: 4000 Blue Ridge Rd, Ste. 170 Raleigh, NC 27612
  • Telephone: 919-784-0410
  • Fax:  919-784-0416
  • Join our Mailing List

Follow Us